224 related articles for article (PubMed ID: 3869801)
1. Methicillin- and gentamicin-resistant Staphylococcus aureus: susceptibility to fosfomycin, cefamandole, N-formimidoyl-thienamycin, clindamycin, fusidic acid and vancomycin.
Graninger W; Leitha T; Breyer S; Francesconi M; Lenz K; Georgopoulos A
Drugs Exp Clin Res; 1985; 11(1):23-7. PubMed ID: 3869801
[TBL] [Abstract][Full Text] [Related]
2. In vitro susceptibility of methicillin-resistant Staphylococcus aureus to imipenem and other antimicrobial agents.
Ishag AJ; Durgham SM; Shibl AM
Chemioterapia; 1987 Aug; 6(4):261-3. PubMed ID: 3477333
[TBL] [Abstract][Full Text] [Related]
3. [In vitro study of the cefamandole-fosfomycin combination against methicillin-resistant staphylococci].
Fosse T; David MF; Duluc F; Darmusey D; Tamalet C; Toga B
Pathol Biol (Paris); 1984 Jun; 32(5 Pt 2):528-31. PubMed ID: 6462742
[TBL] [Abstract][Full Text] [Related]
4. [Incidence, frequency and resistance characteristics of methicillin-oxacillin resistant Staphylococcus aureus strains in Germany].
Voss A; Machka K; Lenz W; Milatovic D
Dtsch Med Wochenschr; 1992 Dec; 117(50):1907-12. PubMed ID: 1459021
[TBL] [Abstract][Full Text] [Related]
5. Gentamicin- and methicillin-resistant, clinical isolates of Staphylococcus aureus: comparative in vitro and in vivo efficacy of alternative antimicrobial drugs.
Traub WH; Spohr M; Bauer D
Chemotherapy; 1984; 30(2):102-12. PubMed ID: 6559664
[TBL] [Abstract][Full Text] [Related]
6. In-vitro antibacterial activity of fusidic acid alone and in combination with other antibiotics against methicillin-sensitive and -resistant Staphylococcus aureus.
Drugeon HB; Caillon J; Juvin ME
J Antimicrob Chemother; 1994 Dec; 34(6):899-907. PubMed ID: 7730233
[TBL] [Abstract][Full Text] [Related]
7. In vitro activities of teichomycin, fusidic acid, flucloxacillin, fosfomycin, and vancomycin against methicillin-resistant Staphylococcus aureus.
Guenthner SH; Wenzel RP
Antimicrob Agents Chemother; 1984 Aug; 26(2):268-9. PubMed ID: 6237606
[TBL] [Abstract][Full Text] [Related]
8. Antistaphylococcal activity of teicoplanin in Riyadh, Saudi Arabia.
Shibl AM; Ishag AH; Durgham SM
APMIS Suppl; 1988; 3():68-70. PubMed ID: 2972301
[TBL] [Abstract][Full Text] [Related]
9. [Predominance of multidrug resistant strains with reduced susceptibility to fusidic acid among methicillin-resistant Staphylococcus aureus strains (MRSA) isolated in the Gdánsk region].
Wiśniewska K; Piechowicz L; Galiński J
Pol Merkur Lekarski; 2000 Nov; 9(53):746-50. PubMed ID: 11204320
[TBL] [Abstract][Full Text] [Related]
10. Comparative activity of CGP 31608, nafcillin, cefamandole, imipenem, and vancomycin against methicillin-susceptible and methicillin-resistant staphylococci.
Sachdeva M; Hackbarth C; Stella FB; Chambers HF
Antimicrob Agents Chemother; 1987 Oct; 31(10):1549-52. PubMed ID: 3481245
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of fluoroquinolones, vancomycin, and gentamicin against methicillin-resistant Staphylococcus aureus ocular isolates.
Kotlus BS; Wymbs RA; Vellozzi EM; Udell IJ
Am J Ophthalmol; 2006 Nov; 142(5):726-9. PubMed ID: 17056356
[TBL] [Abstract][Full Text] [Related]
12. In vitro activity of fosfomycin, alone and in combination, against methicillin-resistant Staphylococcus aureus.
Alvarez S; Jones M; Berk SL
Antimicrob Agents Chemother; 1985 Nov; 28(5):689-90. PubMed ID: 3853963
[TBL] [Abstract][Full Text] [Related]
13. [In vitro study of the effects of an imipenem-fosfomycin combination against clinical strains of Staphylococcus].
Fosse T; David MF; Duluc F
Pathol Biol (Paris); 1986 Dec; 34(10):1055-9. PubMed ID: 3547260
[TBL] [Abstract][Full Text] [Related]
14. Effects of antibiotic combinations on methicillin-resistant Staphylococcus aureus in vitro.
Chang SC; Hsieh WC; Luh KT; Ho SW
Taiwan Yi Xue Hui Za Zhi; 1989 May; 88(5):488-92. PubMed ID: 2794948
[TBL] [Abstract][Full Text] [Related]
15. Microbiological indications for the treatment of Staphylococcus aureus infections.
Fabbri A; Tacchella A; Belli ML; Losurdo G
Chemioterapia; 1988 Dec; 7(6):378-81. PubMed ID: 3219748
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity of fosfomycin combined with rifampin, pefloxacin and imipenem against staphylococci: a study by the time-kill curve method.
Quentin C; Saivin S; Lafferriere C; Noury P; Bebear C
Drugs Exp Clin Res; 1987; 13(4):219-24. PubMed ID: 3476291
[TBL] [Abstract][Full Text] [Related]
17. In-vitro effects of vancomycin, rifampicin, and fusidic acid, alone and in combination, against methicillin-resistant Staphylococcus aureus.
Foldes M; Munro R; Sorrell TC; Shanker S; Toohey M
J Antimicrob Chemother; 1983 Jan; 11(1):21-6. PubMed ID: 6826485
[TBL] [Abstract][Full Text] [Related]
18. In vitro activity of N-formimidoyl thienamycin and other beta-lactam antibiotics against methicillin-resistant Staphylococcus aureus.
Thompson RL; Fisher KA; Wenzel RP
Antimicrob Agents Chemother; 1982 Feb; 21(2):341-3. PubMed ID: 6951505
[TBL] [Abstract][Full Text] [Related]
19. The in-vitro activity of some antimicrobial agents against methicillin-resistant Staphylococcus aureus.
Moorhouse EC; Mulvihill TE; Jones L; Mooney D; Falkiner FR; Keane CT
J Antimicrob Chemother; 1985 Mar; 15(3):291-5. PubMed ID: 3158632
[TBL] [Abstract][Full Text] [Related]
20. In vitro activity of fosfomycin against methicillin-susceptible and methicillin-resistant Staphylococcus aureus.
Graninger W; Leitha T; Havel M; Georgopoulos A
Infection; 1984; 12(4):293-5. PubMed ID: 6092279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
